Treatment of Canker Sores in Children
For children with canker sores (recurrent aphthous stomatitis), topical barrier-forming agents containing hyaluronic acid or topical corticosteroids are the most appropriate first-line treatments, with oral acyclovir reserved for severe cases of herpetic gingivostomatitis if viral etiology is confirmed.
Distinguishing Viral from Aphthous Ulcers
The first critical step is determining whether the lesions are true canker sores (aphthous ulcers) or herpetic gingivostomatitis, as treatment differs significantly:
- Herpetic gingivostomatitis (HSV): Multiple small vesicles that rupture, affecting keratinized tissue (gums, hard palate), often with fever and systemic symptoms
- Aphthous ulcers: Discrete, round ulcers with yellow-gray base and red halo, affecting non-keratinized mucosa (inside lips, cheeks, tongue), without systemic symptoms
Treatment for Confirmed Aphthous Ulcers (True Canker Sores)
First-Line Topical Therapy
Barrier-forming agents with hyaluronic acid are highly effective and safe for pediatric use 1. These products:
- Reduce lesion size by 77-81% within 7 days
- Achieve complete healing in 56-72% of cases
- Provide pain relief without systemic absorption
- Available as both rinse and gel formulations (gel shows faster improvement within 3 days)
Topical benzocaine products (e.g., Red Cross Canker Sore Medication, Orajel) provide immediate pain relief 2, though they address symptoms rather than healing.
Alternative Topical Options
- Amlexanox 5% paste: Most effective evidence-based treatment for reducing ulcer size, pain duration, and healing time 3
- Topical honey: Shown to reduce hospital stay duration in severe cases 4, safe and accessible for pediatric use
- Mucoadhesive tablets with citrus oil and magnesium: Reduce pain and healing time over 8 hours 5
Important Preventive Measure
Switch to SLS-free toothpaste 6. Sodium lauryl sulfate (found in most commercial toothpastes) significantly increases ulcer frequency, duration, number of episodes, and pain. This simple change provides consistent benefit across all measured parameters.
Treatment for Herpetic Gingivostomatitis (If Viral)
If HSV infection is confirmed or strongly suspected:
Mild Cases
- Oral acyclovir: 20 mg/kg/dose (maximum 400 mg) three times daily for 5-10 days 7
Moderate to Severe Cases
- IV acyclovir: 5-10 mg/kg/dose three times daily 7
- Transition to oral therapy once lesions begin regressing
- Continue until complete healing
Critical caveat: Valacyclovir and famciclovir lack pediatric formulations and dosing data, making acyclovir the preferred antiviral 7.
Pain Management
For significant pain interfering with eating or sleep:
- Oral acetaminophen (weight-appropriate dosing)
- Topical 2.5% lidocaine ointment (use cautiously to avoid excessive systemic absorption)
- Avoid aspirin in children due to Reye's syndrome risk
What NOT to Use
- Tetracyclines (doxycycline, minocycline): Contraindicated in children <8 years due to tooth discoloration 8, 9
- Topical penicillin troches: While one study showed efficacy 10, this is not standard practice and allergy risk must be considered
- Low-level laser therapy: Meta-analysis shows no significant benefit for prevention or treatment 4
Common Pitfalls
- Misdiagnosing HSV as aphthous ulcers: HSV requires antiviral therapy; aphthous ulcers do not
- Using systemic antibiotics: Canker sores are not bacterial infections and do not respond to antibiotics
- Prescribing corticosteroids for viral lesions: This can worsen HSV infections
- Overlooking SLS in toothpaste: This modifiable factor significantly impacts recurrence
When to Escalate Care
Refer to pediatric dentistry or oral medicine if:
- Ulcers persist >2 weeks despite treatment
- Frequent recurrences (>6 episodes/year) suggesting underlying systemic disease
- Severe pain interfering with nutrition/hydration
- Suspicion of Behçet's disease, inflammatory bowel disease, or immunodeficiency
The evidence base for pediatric canker sore treatment relies primarily on adult studies and limited pediatric research 11, but topical barrier agents and SLS-free toothpaste represent safe, effective interventions with minimal risk.